Shopping Cart
- Remove All
- Your shopping cart is currently empty
NAcM-OPT HCL is an orally bioavailable cullin neddylation 1 (DCN1) inhibitor that targets N-Acetyl-UBE2M (E2 conjugating enzyme, UBC12) interaction with DCN1 with IC50 of 79 nM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | 30 € | In Stock | |
5 mg | 44 € | In Stock | |
10 mg | 79 € | In Stock | |
25 mg | 143 € | In Stock | |
50 mg | 239 € | In Stock | |
100 mg | 391 € | In Stock | |
500 mg | 928 € | In Stock | |
1 mL x 10 mM (in DMSO) | 84 € | In Stock |
Description | NAcM-OPT HCL is an orally bioavailable cullin neddylation 1 (DCN1) inhibitor that targets N-Acetyl-UBE2M (E2 conjugating enzyme, UBC12) interaction with DCN1 with IC50 of 79 nM. |
In vivo | NAcM-OPT is orally bioavailable, well tolerated in mice, and currently used to study the effects of acute pharmacologic inhibition of the DCN1-UBE2M interaction on the NEDD8/CUL pathway |
Molecular Weight | 470.86 |
Formula | C23H30Cl3N3O |
Cas No. | 2416146-10-4 |
Smiles | Cl.CCCCN1CCC(CC1)N(Cc1ccccc1)C(=O)Nc1ccc(Cl)c(Cl)c1 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 60 mg/mL (127.43 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.